Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis

Pingan Ding,Jiaxiang Wu,Haotian Wu,Tongkun Li,Jiaxuan Yang,Li Yang,Honghai Guo,Yuan Tian,Peigang Yang,Lingjiao Meng,Qun Zhao
DOI: https://doi.org/10.1111/eci.14201
2024-03-29
European Journal of Clinical Investigation
Abstract:This study reveals that preoperative CT‐defined myosteatosis is an independent predictor of increased postoperative complications and reduced survival in robotic gastrectomy for gastric cancer. Analysing 246 patients, myosteatosis was identified in 33.6%, associated with higher overall (47.7% vs. 26.5%) and severe complications (12.4% vs. 4.9%). It also correlated with decreased overall (85.0% vs. 93.2%) and disease‐free survival (80.3% vs. 88.4%). These findings suggest assessing myosteatosis on preoperative CT could significantly improve patient management and outcomes. Background Robotic gastrectomy is increasingly utilized for gastric cancer, but high morbidity remains a concern. Myosteatosis or low skeletal muscle density reflecting fatty infiltration, associates with complications after other cancer surgeries but has not been evaluated for robotic gastrectomy. Methods This retrospective study analysed 381 patients undergoing robotic gastrectomy for gastric cancer from September 2019 to October 2022. Myosteatosis was quantified on preoperative computed tomography (CT) images at lumbar 3 (L3). Propensity score matching addressed potential confounding between myosteatosis and non‐myosteatosis groups. Outcomes were postoperative complications, 30 days mortality, 30 days readmissions and survival. Results Myosteatosis was present in 33.6% of patients. Myosteatosis associated with increased overall (47.7% vs. 26.5%, p
medicine, general & internal, research & experimental
What problem does this paper attempt to address?